BRIDGETT HARR: Open Payments
NPI 1609121045 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $547 · 2025 $648
Food & beverage: $555Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $140 |
| Novartis Pharmaceuticals Corporation | 1 | $133 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $110 |
| Astellas Pharma US Inc | 1 | $93 |
| Pharmacosmos Therapeutics Inc. | 1 | $48 |
Products named: EPKINLY, KISQALI, Vanflyta, Orserdu, MONOFERRIC.
Industry payments across OH — which companies pay providers there.
